Joshua D Mezrich
Overview
Explore the profile of Joshua D Mezrich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
1963
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Couillard A, Knott E, Zlevor A, Mezrich J, Cristescu M, Agarwal P, et al.
J Vasc Interv Radiol
. 2022 Jun;
33(9):1045-1053.
PMID: 35667580
Purpose: To evaluate the efficacy and safety of microwave (MW) ablation as first-line locoregional therapy (LRT) for bridging patients with hepatocellular carcinoma (HCC) to liver transplant. Materials And Methods: This...
2.
Al-Qaoud T, Al-Adra D, Mezrich J, Fernandez L, Kaufman D, Odorico J, et al.
Exp Clin Transplant
. 2021 Apr;
19(5):425-433.
PMID: 33797353
Objectives: Despite advances in surgical techniques and organ preservation, transplant ureteric strictures remain a common complication in kidney transplantation. A variety of endourological and surgical techniques have been utilized; however,...
3.
Yankol Y, Bugeaud E, Zens T, Rizzari M, Mecit N, Leverson G, et al.
Turk J Med Sci
. 2020 Oct;
51(2):610-622.
PMID: 33037873
Background/aim: The progression of chronic kidney disease (CKD) in recipients of living-donor liver transplant (LDLT) compared to deceased-donor liver transplant (DDLT) has not been studied in the literature. We hypothesize...
4.
Parajuli S, Aziz F, Blazel J, Muth B, Garg N, Mohamed M, et al.
Transplantation
. 2020 Aug;
105(7):1548-1555.
PMID: 32732618
Background: There is limited information about the utility of donor-specific antibody (DSA) against HLA monitoring and the role of protocol kidney biopsy for de novo DSA (dnDSA) in simultaneous liver...
5.
Bath N, Leverson G, Al-Adra D, DAlessandro A, Mezrich J, Foley D
Liver Transpl
. 2020 May;
26(9):1127-1137.
PMID: 32453905
The acceptable threshold remains unknown for the percentage of macrosteatosis (MaS) and microsteatosis (MiS) to yield optimal outcomes after donation after circulatory death (DCD) liver transplantation (LT). The purpose of...
6.
Garg N, Hidalgo L, Ellis T, Redfield R, Parajuli S, Mezrich J, et al.
Am J Transplant
. 2020 May;
20(12):3443-3450.
PMID: 32402138
Third-party vascular allografts (VAs) are an invaluable resource in kidney and pancreas transplantation when vascular reconstruction is needed and additional vessels from the organ donor are not available. We report...
7.
Groose M, Aldred B, Mezrich J, Hammel L
Liver Transpl
. 2019 Aug;
25(12):1851.
PMID: 31433894
No abstract available.
8.
Groose M, Aldred B, Mezrich J, Hammel L
Liver Transpl
. 2019 May;
25(11):1682-1689.
PMID: 31119833
Intracardiac thrombus (ICT) is an intraoperative complication with high mortality that occurs during orthotopic liver transplantation (OLT). Patients with end-stage liver disease have compromised coagulation pathways, and when combined with...
9.
Zimmermann C, Baggett N, Taylor L, Buffington A, Scalea J, Fost N, et al.
Am J Transplant
. 2019 Feb;
19(8):2232-2240.
PMID: 30768840
Donation before circulatory death for imminently dying patients has been proposed to address organ scarcity and harms of nondonation. To characterize stakeholder attitudes about organ recovery before circulatory death we...
10.
ODriscoll C, Gallo M, Fechner J, Schauer J, Mezrich J
Toxicology
. 2019 Jan;
414:14-26.
PMID: 30611761
Atmospheric particulate matter (PM) is a complex component of air pollution and the leading environmental risk factor for death worldwide. PM is formed from a combination of primary sources that...